First human trial of engineered T cells

Senior Editor Markus Elsner talks to Alex Marson of UCSF about the significance of a Science paper describing the phase 1 clinical trial of CRISPR-engineered T cells. The work was carried out by Carl June and Edward Stadtmauer from UPenn. Read the paper here.

Hosted on Acast. See acast.com/privacy for more information.

More from Forum

  1. 41:57From Bench to Podcast: Stories from Biotech Labs- Marcus WalkerApr 16, 2024
  2. 34:53Protein Design Roundtable: Deane and GrigoryanFeb 01, 2024
  3. 37:27Super Resolution and Expansion Microscopy Roundtable: Boyden and DanzlJun 29, 2023
  4. 47:11Single-cell metabolomics Roundtable: Alexandrov and LeApr 26, 2023
  5. 36:33Microbiome Roundtable: Fischbach and MazmanianMar 01, 2023
  6. 31:13Xenotransplantation Roundtable: Locke and SykesDec 21, 2022
  7. 45:26Human Cell Atlas Roundtable: Regev and TeichmannAug 31, 2022
  8. 40:50PROTACs Roundtable: Bertozzi and DeshaiesJul 18, 2022
  9. 46:073D Genome Roundtable: Pombo and Phillips-CreminsMay 16, 2022
  10. 47:34CRISPR Screening Roundtable: Stegmaier and DoenchApr 06, 2022